Skip to main content
21 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
C. Difficile - Clostridium Difficile
C. difficile - Clostridium difficile
Destiny Pharma advances strategy against bacteria
Read more
Novacta targets C. difficile the natural way
Read more
Novacta targets C. difficile the natural way
Read more
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
